NCT01369433 2020-09-01
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
AVEO Pharmaceuticals, Inc.
Phase NA Terminated
AVEO Pharmaceuticals, Inc.
EMD Serono
Wyeth is now a wholly owned subsidiary of Pfizer